What is United Therapeutics's total revenue?

United Therapeutics (UTHR) reported total revenue of $781.5M in Q1 2026.

How has United Therapeutics's total revenue changed year-over-year?

United Therapeutics's total revenue decreased by 1.6% year-over-year, from $794.4M to $781.5M.

What is the long-term trend for United Therapeutics's total revenue?

Over 4 years (2021 to 2025), United Therapeutics's total revenue has grown at a 17.2% compound annual growth rate (CAGR), from $1.69B to $3.18B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

United Therapeutics UTHR Total Revenue

Total Revenue at other companies

Tenet HealthcareTHC

$5.37B+2.8%

Johnson & JohnsonJNJ

$24.06B+9.9%

Merck & Co.MRK

$16.29B+4.9%

InsmedINSM

$305.96M+230%

Ethos Technologies, Inc. LIFE

$0—

LQD

Liquidia CorporationLQDA

$132.87M+4,158%

Segments

By product

See full

Tyvaso DPI$330.3M+9.2%

Orenitram$135.6M+12.3%

Nebulized Tyvaso$127.2M-22.3%

Remodulin$126.6M-8.4%

Unituxin$53.6M-7.9%

Adcirca$2.9M-51.7%

By geography

See full

U.S.$749.6M—

Other financials

Income statement

See full

Gross profit$648.1M-7.7%

Operating income$325.8M-14.9%

Net income$274.9M-14.7%

EPS (diluted)$5.82-12.2%

Balance sheet

See full

Cash & equivalents$1.3B-32.6%

Total debt$12.2M—

Total equity$5.9B-13.3%

Total assets$6.7B-13.3%

Cash flow

See full

Operating cash flow$463.3M+0.5%

CapEx$100.8M+34.6%

Free cash flow$362.5M-6.2%

Valuation

See full

Market cap$23B+84.1%

P/E17.9×+7.8×

P/S7.3×+3.2×

Profitability

See full

Gross margin86.6%-2.4pp

Operating margin45.3%-1.6pp

Net margin40.6%+0.2pp

FCF margin32.1%-5.6pp

Returns & leverage

See full

Return on equity20.3%+0.3pp

Debt / equity0×—

Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is United Therapeutics's total revenue?: United Therapeutics (UTHR) reported total revenue of $781.5M in Q1 2026.
How has United Therapeutics's total revenue changed year-over-year?: United Therapeutics's total revenue decreased by 1.6% year-over-year, from $794.4M to $781.5M.
What is the long-term trend for United Therapeutics's total revenue?: Over 4 years (2021 to 2025), United Therapeutics's total revenue has grown at a 17.2% compound annual growth rate (CAGR), from $1.69B to $3.18B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.